Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner

Journal of Cell Biology

Volumn 146, Issue 1, 1999, Pages 149-164

  Nguyen, Diem H D ^a   Catling, Andrew D ^a   Webb, Donna J ^a   Sankovic, Mauricio ^a   Walker, Lori A ^a   Somlyo, Avril V ^a   Weber, Michael J ^a   Gonias, Steven L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Cellular migration; Integrins; Myosin light chain kinase; Urokinase type plasminogen activator; Vitronectin

Indexed keywords

INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN KINASE; RAS PROTEIN; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL MIGRATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIBODIES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL ADHESION; CELL MOVEMENT; ENZYME ACTIVATION; FLAVONOIDS; HUMANS; INTEGRINS; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUTATION; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHORYLATION; PLASMINOGEN ACTIVATORS; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RAS PROTEINS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; VITRONECTIN;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033549558     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.146.1.149     Document Type: Article

References (92)

1. Adelstein, R.S., M.D. Pato, J.R. Sellers, P. de Lanerolle, and M.A. Conti. 1982. Regulation of contractile proteins by reversible phosphorylation of myosin and myosin kinase. In Basic Biology of Muscles: A Comparative Approach. B.M. Twarog, R.J.C. Levine, and M.M. Dewey, editors. Raven Press, New York. 273-281.
2. Amano, M., M. Ito, K. Kimura, Y. Fukata, K. Chihara, T. Nakano, Y. Matsuura, and K. Kaibuchi. 1996. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271:20246-20249.
3. Andreasen, P.A., L. Kjøller, L. Christensen, and M.J. Duffy. 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer. 72:1-22.
4. Bohuslav, J., V. Horejsí, C. Hansmann, J. Stöckl, U.H. Weidle, O. Majdic, I. Bartke, W. Knapp, and H. Stockinger. 1995. Urokinase plasminogen activator receptor, β-integrins, and src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 181:1381-1390.
5. Braut-Boucher, F., J. Pichon, P. Rat, M. Adolphe, M. Aubery, and J. Font. 1995. A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes. J. Immunol. Methods. 178:41-51.
6. Bresnick, A.R. 1999. Molecular mechanisms of nonmusde myosin-II regulation. Curr Opin. Cell Biol. 11:26-33.
7. 5;? to promote tumor cell dissemination in vivo. J. Clin. Invest. 99:1390-1398.
8. Busso, N., S.K. Masur, D. Lazega, S. Waxman, and L. Ossowski. 1994. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126: 259-270.
9. Cai, H., J. Szeberenyi, and G.M. Cooper. 1990. Effect of a dominant inhibitory H-Ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10:5314-5323.
10. Cande, W.Z., and R.M. Ezzell. 1986. Evidence for regulation of lamellipodial and tail contraction of glycerinated chicken embryonic fibroblasts by myosin light chain kinase. Cell Motil. Cytoskelet. 6:640-648.
11. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degan, R. Bronson, R. De Vos, J.J. van den Oord, D. Collen, and R.C. Mulligan. 1994. Physiologic consequences of loss of plasminogen activator gene function in mice. Nature. 368:419-424.
12. Catling, A.D., H.J. Schaeffer, C.W. Reuter, G.R. Reddy, and M.J. Weber. 1995. A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function. Mol. Cell. Biol. 15:5214-5225.
13. Chapman, H.A. 1997. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9:714-724.
14. Chrzanowska-Wodnicka, M., and K. Burridge. 1996. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol. 133: 1403-1415.
15. Chu, Y., P.A. Solski, R. Khosravi-Far, C.J. Der, and K. Kelly. 1996. The MAP kinase phosphatases PAC1, MKP-1 and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271:6497-6501.
16. Clarke, P.R. 1994. Switching off MAP kinases. Curr. Biol. 4:647-650.
17. Cohen, R.L., X.-P. Xi, C.W. Crowley, B.K. Lucas, A.D. Levinson, and M.A. Shuman. 1991. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood. 78:479-487.
18. Conese, M., A. Nykjaer, C.M. Petersen, O. Cremona, R. Pardi, P.A. Adreasen, J. Gleimann, E.I. Christensen, and F. Blasi. 1995. Alpha-2 macroglodulin receptor/Ldl receptor-related protein (Lrp)-dependent internalization of the urokinase receptor. J. Cell Biol. 131:1609-1622.
19. 5 integrin is localized at focal contacts by HT-1080 fibrosarcoma cells and human fibroblasts attached to vitronectin. Cell Adhes. Commun. 1:279-293.
20. Corbalan-Garcia, S., S.-S. Yang, K.R. Degenhardt, and D. Bar-Sagi. 1996. Identification of the mitogen-activated protein kinase phosphorylation sites on human Sosl that regulate interaction with Grb2. Mol. Cell. Biol. 16:5674-5682.
21. Cowley, S., H. Paterson, P. Kemp, and C.J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:841-852.
22. de Munk, G.A.W., and D.C Rijken. 1990. Fibrinolytic properties of single chain urokinase-type plasminogen activator. Fibrinolysis. 4:1-9.
23. Dumler, I., T. Petri, and W.-D. Schleuning. 1993. Interaction of urokinase-type plasminogen activator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett. 322:37-40.
24. Dumler, I., A. Weis, O.A. Mayboroda, C. Maasch, U. Jerke, H. Haller, and D.C. Gulba. 1998. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J. Biol. Chem. 273:315-321.
25. 3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell. Biol. 140:1255-1263.
26. Ellis, V., and K. Dano. 1992. The urokinase receptor and the regulation of cell surface plasminogen activation. Fibrinolysis. 6:27-43.
27. Ellis, V., M.F. Scully, and V.V. Kakkar. 1989. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J. Biol. Chem. 264:2185-2188.
28. 2+-independent contraction of smooth muscle. J. Biol. Chem. 273:23433-23439.
29. Filardo, E.J., S.L. Deming, and D.A. Cheresh. 1996. Regulation of cell migration by the integrin β subunit ectodomain. J. Cell Sci. 109:1615-1622.
30. Frost, J.A., H. Steen, P. Shapiro, R. Lewis, N. Ahn, P.E. Shaw, and M.H. Cobb. 1997. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO (Eur. Mol. Biol. Org.) J. 16:6426-6438.
31. Garcia, J.G.N., H.W. Davis, and C.E. Patterson. 1995. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J. Cell. Phys. 163:510-522.
32. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature. 358:414-424.
33. Goeckeler, Z.M., and R.B. Wysolmerski. 1995. Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J. Cell Biol. 130: 613-627.
34. Gonzalez, F.A., A. Seth, D.L. Raden, D.S. Bowman, F.S. Fay, and R.J. Davis. 1993. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J. Cell Biol. 122:1089-1101.
35. Gyetko, M.R., G.-H. Chen, R.A. McDonald, R. Goodman, G.B. Huffnagla, C.C. Wilkinson, J.A. Fuller, and G.B. Toews. 1996. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. J. Clin. Invest. 97:1818-1826.
36. Hayman, E.G., M.D. Pierschbacker, S. Suzuki, and E. Ruoslahti. 1985. Vitronectin - a major cell attachment-promoting protein in fetal bovine serum. Exp. Cell Res. 160:245-258.
37. Hidaka, H., Y. Saski, T. Tanaka, T. Endo, S. Ohno, Y. Fujii, and T. Nagata. 1981. N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc. Natl. Acad. Sd. USA. 78:4354-4357.
38. 2+, calmodulin-dependent myosin light chain phosphorylation of smooth muscle and nonmuscle cells. In Advances in Second Messenger and Phosphoprotein Research. Vol. 21. R. Adelslein, C. Klee, and M. Rodbell, editors. Raven Press, New York. 95-99.
39. Hill, C.A., and R. Treisman. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 80:199-211.
40. Hipskind, R.A., M. Baccarini, and A. Nordheim. 1994. Transient activation of Raf-1 MEK and ERK coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo. Mol. Cell. Biol. 14:6219-6231.
41. Hughes, P.E., M.W. Renshaw, M. Pfaff, J. Forsyth, V.M. Keivens, M.A. Schwartz, and M.H. Ginsberg. 1997. Suppression of integrin activation: a novel function of a ras/raf-initiated MAP kinase pathway. Cell. 88:521-530.
42. Jay, P.Y., P.A. Pham, S.A. Wong, and E.L. Elson. 1995. A mechanical function of myosin II in cell motility. J. Cell Sci. 108:387-393.
43. Kanemitsu, M. Y., and A.F. Lau. 1993. Epidermal growth factor stimulates the disruption of gap junctional communication and connexin 43 phosphorylation independent of 12-O-tetradecanoylphorbol 13-acetate-sensilive protein kinase C: the possible involvement of mitogen activated protein kinase. Mol. Biol. Cell. 4:837-848.
44. Kanse, S.M., O. Benzakour, C. Kanthou, C. Kost, H.R. Lijnen, and K.T. Preissner. 1997. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arterioscler. Throm. Vasc. Biol. 17:2848-2854.
45. Keyse, S.M. 1995. An emerging family of dual specificity MAP kinase phosphatases. Biochim. Biophys. Acta. 1265:152-160.
46. 5-directed cell motility but not adhesion on vitroneclin. J. Cell Biol. 127:859-866.
47. Klemke, R.L., S. Cai, A.L. Giannini, P.J. Gallagher, P. de Lanerolle, and D.A. Cheresh. 1997. Regulation of cell motility by mitogen-activaled protein kinase. J. Cell Biol. 137:481-492.
48. Kolega, J., and D.L. Taylor. 1993. Gradients in the concentration and assembly of myosin II in living fibroblasts during locomotion and fiber transport. Mol. Biol. Cell. 4:819-836.
49. Komatsu, S., N. Murai, G. Totsukawa, M. Abe, K. Akasaka, H. Shimada, and H. Hosoya. 1997. Identification of MAPKAPK homolog (MAPAPK-4) as a myosin II regulatory light-chain kinase in sea urchin egg extracts. Arch. Biochem. Biophys. 343:55-62.
50. Konakova, M., F. Hucho, and W.-D. Schleuning. 1998. Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur. J. Biochem. 253:421-429.
51. Koopman, J.L., J. Slomp, A.C.W. de Bart, P.H.A. Quax, and J.H. Verheijen. 1998. Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor. J. Biol Chem. 273:33267-33272.
52. Koshelnick, Y., M. Ehart, P. Hufnag, P.C. Heinrich, and B.R. Binder. 1997. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598.J. Biol. Chem. 272:28563-28567.
53. Lamb, N.J., A. Fernandez, M.A. Conti, R. Adelstein, D.B. Glass, W.J. Welch, and J.R. Feramisco. 1988. Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase. J. Cell Biol. 106:1955-1971.
54. Lauffenburger, D.A., and A.F. Horwitz. 1996. Cell migration: a physically integrated molecular process. Cell. 84:359-369.
55. Laug, W.E., K. Wang, R. Mundi, W. Rideout III, E.K.O. Kruithof, and E. Bogenmann. 1992. Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT 1080 sarcoma cells. Int. J. Cancer. 52:298-304.
56. Lin, L.-L., M. Wartmann, A.Y. Lin, J.L. Knopf, A. Seth, and R.J. Davis. 1993. CPLA2 is phosphorylated and activated by MAP kinase. Cell. 72:269-278.
57. Lisanti, M.P., M.C. Field, I.W. Caras, A.K. Menon, and E. Rodriquez-Boulan. 1991. Mannosamine, a novel inhibitor of glycosyl-phosphatidylinositol incorporation into proteins. EMBO (Eur. Mol. Biol. Org.) J. 10:1969-1977.
58. Manchanda, N., and B.S. Schwartz. 1991. Single-chain urokinase: augmentation of enzymatic activity upon binding to monocytes. J. Biol. Chem. 266:14580-14584.
59. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell. 73:381-393.
60. Matsumura, F., S. Ono, Y. Yamakita, G. Totsukawa, and S. Yamashiro. 1998. Specific localization of serine 19 phosphorylated myosin II during cell locomotion and mitosis of cultured cells. J. Cell Biol. 140:119-129.
61. 2 integrins in vivo. J. Exp. Med. 188:1029-1037.
62. v integrins and vitronectin receptor identity in breast cancer cells. Br. J. Cancer. 77:530-536.
63. Mirshahi, S.S., K.C. Lounes, H. Lu, E. Pujade-Lauraine, Z. Mishal, J. Bénard, A. Bernadou, C. Soria, and J. Soria. 1997. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation. FEBS Lett. 411:322-326.
64. 1-Adrenoceptor-mediated phosphorylation of myosin in rat-tail arterial smooth muscle. Biochem. J. 327:669-674.
65. Moores, S.L., J.H. Sabry, and J.A. Spudich. 1996. Myosin dynamics in live Dictyostelium cells. Proc. Natl. Acad. Sci. USA. 93:443-446.
66. Nguyen, D.H.D., I.M. Hussaini, and S.L. Gonias. 1998. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J. Biol. Chem. 273:8502-8507.
67. Odekon, L.E., Y. Sato, and D.B. Rifkin. 1992. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell. Phys. 150:258-263.
68. Ploug, M., E. Rønne, N. Behrendt, A.L. Jensen, F. Blasi, and K. Dano. 1991. Cellular receptor for urokinase plasminogen activator. J. Biol. Chem. 266: 1926-1933.
69. Resnati, M., M. Guttiner, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli. 1996. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO (Eur. Mol. Biol. Org.) J. 15:1572-1582.
70. Reszka, A.A., R. Seger, C.D. Diltz, E.G. Krebs, and E.H. Fischer. 1995. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc. Natl. Acad. Sci. USA. 92:8881-8885.
71. Saitoh, M., T. Ishikawa, S. Matsushima, M. Naka, and H. Hidaka. 1987. Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J. Biol. Chem. 262:7796-7801.
72. Sanders, L.C., F. Matsumura, G.M. Bokoch, and P. de Lanerolle. 1999. Inhibition of myosin light chain kinase by p21-activated kinase. Science. 283:2083-2085.
73. Shapiro, R.L., J.G. Duguette, I. Nunes, D.F. Roses, M.N. Harris, E.L. Wilson, and D.B. Rifkin. 1997. Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles. Am. J. Pathol. 150:359-369.
74. Simon, D.I., N.K. Rao, H. Xu, Y. Wei, O. Majdic, E. Ronne, L. Kobzik, and H.A. Chapman. 1996. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood. 88:3185-3194.
75. Sitrin, R.G., R.F. Todd III, H.R. Petty, T.G. Brock, S.B. Shollenberger, E. Albrecht, and MR. Gyetko. 1996. The urolinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J. Clin. Invest. 97: 1942-1951.
76. 3 binding to vitronectin. Nature. 383:441-443.
77. 2+ desensitization. Mol. Cell. Biochem. 127/128:229-237.
78. Tan, J.L., S. Ravid, and J.A. Spudich. 1992. Control of nonmuscle myosins by phosphorylation. Annu. Rev. Biochem. 61:721-759.
79. Tang, H., D.M. Kerins, Q. Hao, T. Inagami, and D.E. Vaughan. 1998. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J. Biol. Chem. 273:18268-18272.
80. Tkachuk, V., V. Stepanova, P.J. Little, and A. Bobik. 1996. Regulation of urokinase plasminogen activator in vascular remodelling. Clin. Exp. Pharmacol. Physiol. 23:759-765.
81. Tsuboi, R., and D.B. Rifkin. 1990. Biomodal relationship between invasion of the amniotic membrane and plasminogen activator activity. Int. J. Cancer. 46:56-60.
82. Wang, J., A. Mazar, N. Quan, A. Schneider, and J. Henkin. 1997. Plasminogen activation by pro-urokinase in complex with its receptor. Eur. J. Biochem. 247:256-261.
83. Weaver, A.M., I.M. Hussaini, A. Mazar, J. Henkin, and S.L. Gonias. 1997. Embryonic fibroblasts that are deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J. Biol. Chem. 272: 14372-14379.
84. Webb, D.J., D.H.D. Nguyen, M. Sankovic, and S.L. Gonias, 1999. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J. Biol. Chem. 274:7412-7420.
85. Wei, Y., D.A. Waltz, N. Rao, R.J. Drummond, S. Rosenberg, and H.A. Chapman. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380-32388.
86. Wei, Y., M. Lukashev, D.I. Simon, S.C. Bodary, S. Rosenberg, M.V. Doyle, and H.A. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science. 273:1551-1555.
87. White, M.A., C. Nicoletle, A. Minden, A. Polverino, L.V. Aelst, M. Karin, and M.H. Wigler. 1995. Multiple ras functions can contribute to mammalian cell transformation. Cell. 80:533-541.
88. Wu, X., T.A.J. Haystead, R.K. Nakamoto, A.V. Somlyo, and A.P. Somlyo, 1998. Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. J. Biol. Chem. 273:11362-11369.
89. Xie, H., M.A. Paler, K. Gupta, P. Chang, M.F. Ware, W. Witke, D.J. Kwiatkowski, D.A. Lauffenburger, J.E. Murphy-Ullrich, and A. Wells. 1998. EFG receptor regulation of cell motility: EGF induces disassembly of focal adhesions in independently of the motilily-associated PLCγ signaling pathway. J. Cell Sci. 111:615-624.
90. 3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res. 57:1682-1689.
91. Yatohgo, T., M. Izumi, H. Kashiwagi, and M. Hayashi. 1988. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 14:281-292.
92. 5-directed cell migration. J. Biol. Chem. 271:29393-29399.